![]() ![]() ![]() All patients had an EDSS score between 3 and 6.5, with patients at a score of 3 able to walk well (despite some muscle weakness), and patients at a 6 or 6.5 requiring assistive devices to ambulate. According to a preliminary analysis of results from the FDA-approved study, these stem cell treatments are the first-ever treatments that improve neurological outcomes in secondary progressive MS (SPMS) and primary progressive MS (PPMS) patients.Īt the onset of the study, researchers calculated each patient’s universally-accepted disability scale (EDSS score), which was measured before their first treatment and again after their sixth stem cell treatment. New York, NY – Ap–New research conducted by the Tisch MS Research Center of New York has found that multiple stem cell treatments may result in substantial improvement in muscle strength of MS patients. New Research Finds That, For The First Time Ever, Stem Cell Treatments Improve Disability Status for Multiple Sclerosis Patients With Progressive Disease Preliminary analysis of FDA-approved study conducted by the Tisch MS Research Center of New York found that stem cell treatments substantially improved muscle strength and disability scores, particularly among patients with lower levels of disability ![]()
0 Comments
Leave a Reply. |